India's drug regulator approves AstraZeneca/Oxford vaccine: sources

FILE PHOTO: An employee in personal protective equipment (PPE) removes vials of AstraZeneca's COVISHIELD, coronavirus disease (COVID-19) vaccine, from a visual inspection machine inside a lab at Serum Institute of India, Pune

NEW DELHI (Reuters) - India's drug regulator on Friday approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, two sources with knowledge of the matter told Reuters.

A representative of India's Central Drugs Standard Control Organization (CDSCO), whose experts were meeting for the second time this week, declined to comment.

(Reporting by Krishna N. Das and Nigam Prusty; Editing by Gareth Jones)